2 Dec 2016 07:00
Collagen Solutions Plc
(the "Company" or the "Group")
Notice of Half Year Results
Analyst Briefing
The Board of Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, will announce their unaudited interim results for the six months ending 30 September 2016 on Monday, 19 December 2016.
A briefing for analysts will take place at Walbrook PR, 4 Lombard Street, London EC3V 9HD at 10.00am on Monday 19 December 2016.
If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email collagen@walbrookpr.com.
Enquiries:
Collagen Solutions Plc | Contact via Walbrook | ||
Jamal Rushdy, Chief Executive Officer |
| ||
Gill Black, Chief Financial Officer |
| ||
|
| ||
Cenkos Securities plc (Nominated Adviser and Broker) Stephen Keys Steve Cox | Tel: 0207 397 8900
| ||
|
| ||
Walbrook PR | Tel: 020 7933 8780 or collagen@walbrookpr.com | ||
Mike Wort | Mob: 07900 608 002 | ||
Anna Dunphy | Mob: 07876 741 001 | ||